News Details
WEBAug 22, 2024 · Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna's updated vaccine is expected to be available in the coming days.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty or the updated, approved Spikevax; if previously vaccinated, the dose is...
Spikevax (COVID-19 Vaccine, mRNA) 2024-2025 Formula - Moderna
WEBLearn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
FDA authorizes Novavax's updated Covid vaccine targeting JN.1 …
WEBNovavax’s traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA — Moderna’s Spikevax and Comirnaty, which is jointly developed by Pfizer...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 · Approval of Spikevax (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, a change to a single dose for individuals 18 years of age and older, and approval of a single dose for individuals...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 …
WEBJun 7, 2024 · CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2024-2025 formula, targeting the SARS-CoV-2 variant JN.1.
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
WEBSep 11, 2023 · SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Coronavirus (COVID-19) Update: FDA Takes Key Action by …
WEBJan 31, 2022 · Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for...
Spikevax® (COVID-19 Vaccine, mRNA) - Moderna
WEBSPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) in individuals 12 years of age and older.
FDA fully approves Moderna COVID vaccine, Spikevax
WEBToday the US Food and Drug Administration (FDA) granted full approval to the mRNA COVID-19 vaccine made by Moderna, which will now be known as Spikevax. The vaccine had been authorized for emergency use for more than a year and has been a mainstay of the US vaccination campaign.